Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 3

2(40.0%)

5Total

N/A(3)

Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT05266625Not ApplicableUnknown

Digital Therapeutic Based Investigation to Improve Glycemic Control in Patients With Type 2 Diabetes and Residual Hyperglycemia on Stable Medical Therapy

Role: lead

NCT05302050Not ApplicableUnknown

A Cognitive Behavioral Digital Therapeutic InterventiON for Glycemic Control in Type 2 Diabetes Mellitus

Role: lead

NCT05094401Phase 3Terminated

Use of an Investigational Digital Therapeutic in Patients With Type 2 Diabetes

Role: lead

NCT04886388Phase 3Completed

Pivotal Trial of a Digital Therapeutic for the Treatment of Type 2 Diabetes

Role: lead

NCT05357248Not ApplicableCompleted

Nutritional Cognitive Behavioral Therapy Feasibility Study in NAFLD and NASH

Role: lead

All 5 trials loaded